It has been four decades since the initiation of President Nixon’s “War on Cancer”, but never have the signs for victory looked so encouraging. This is an exciting phase in cancer research, so much so […]
Consider a case where a patient has a disease with high mortality and no effective treatment available. A new experimental drug is now being tested in a clinical trial. However, this is a randomized clinical […]
BIO2014 begins! The much-awaited 2014 BIO International Convention kicked off with a day of special sessions on Monday, June 23rd, 2014. via Bioethics of Compassionate Use of Drugs: BIO2014.
Protein-protein interactions (PPI) are key regulatory processes in cancer because many proteins that directly interact with binding partners regulate tumor growth. Recognizing this role of PPIs, they have been the focus of recent drug development/discovery […]
Cambridge Healthtech Institute (CHI) organizes the annual Drug Discovery Chemistry (DDC) conference that focuses on drug discovery of small molecule candidates and challenges involved in their optimization. True to its motto “Optimizing Small Molecules For […]